Company news
Hofseth Biocare ASA news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Hofseth BioCare ASA: AECORBIO APPOINTS PROF. KARL G. SYLVESTER AS CO-FOUNDER AND CONSULTING CHIEF MEDICAL OFFICER
November 3, 2026
Hofseth Biocare ASA: approval and publication of listing prospectus
October 9, 2026
Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION
September 17, 2026
Hofseth Biocare ASA: management change
September 1, 2026
Hofseth BioCare ASA: SECOND QUARTER 2026 FINANCIAL REPORT
August 21, 2026
Hofseth Biocare ASA: Notification of major shareholdings
July 31, 2026
Hofseth Biocare ASA: extraordinary general meeting completed
July 30, 2026
Hofseth BioCare ASA: NEW PEER-REVIEWED CLINICAL STUDY ON PROGO® PUBLISHED IN BIOMEDICINES DEMONSTRATES GLP-1 BENEFITS AND AN INCREASE LEAN MUSCLE MASS
July 27, 2026
Hofseth Biocare ASA: notice of extraordinary general meeting
July 9, 2026
Hofseth Biocare ASA: major shareholder notification
July 7, 2026
Hofseth Biocare ASA: new share capital registered
July 3, 2026
Hofseth Biocare ASA: annual general meeting completed
June 30, 2026
Hofseth Biocare ASA: mandatory notification of trade
June 29, 2026
Hofseth Biocare ASA: disclosures of large shareholdings
June 29, 2026
Hofseth Biocare ASA – voting undertakings secured in relation to private placement and b-share amendments
June 29, 2026
Hofseth Biocare ASA: private placement successfully placed
June 28, 2026
Hofseth Biocare ASA: contemplated private placement
June 26, 2026
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026
June 9, 2026
Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M
May 21, 2026
Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas
April 14, 2026
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025
March 27, 2026
Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT
February 13, 2026
Hofseth BioCare ASA: Cancellation of Subsequent Offering – Update on completion of Private Placement
December 15, 2025
Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING
November 21, 2025
Hofseth BioCare ASA: Extraordinary General Meeting completed
November 20, 2025
Hofseth BioCare ASA: LAST DAY OF SUBSCRIPTION PERIOD IN SUBSEQUENT OFFERING
November 20, 2025
Hofseth BioCare ASA: HBC ANNOUNCES STRATEGIC PRODUCT PARTNERSHIP WITH JAMES LAVALLE & METABOLIC ELITE
November 20, 2025
Hofseth BioCare ASA: Publication of the Prospectus – Start of the Subscription Period for the Subsequent Offering
November 10, 2025
Hofseth BioCare ASA: Terms of the Subsequent Offering
November 7, 2025
Hofseth BioCare ASA: THIRD QUARTER 2025 FINANCIAL REPORT
November 7, 2025
Hofseth BioCare ASA: NOTICE OF EXTRAORDINARY GENERAL MEETING
October 30, 2025
Ex. Subsequent Offering Today
October 27, 2025
Hofseth BioCare ASA: Key Information Relating to Subsequent Offering
October 27, 2025
Hofseth BioCare ASA: Disclosures of Large Shareholdings
October 27, 2025
Hofseth BioCare ASA: Private placement successfully placed
October 27, 2025
Hofseth Biocare ASA: USD 5 Million Divestment in Aecorbio
October 24, 2025
Hofseth BioCare ASA: Contemplated Private Placement and Partial Divestment of Shares in Aecorbio
October 24, 2025
Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER
September 17, 2025
Hofseth Biocare ASA: ProGo, the world’s first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myostatin and Activin A pathways
September 9, 2025
Hofseth Biocare ASA: HBC onboards former Head of Nestle Health Science Asia, Oceania, Middle East and Africa Region, Paul Bruhn
September 4, 2025
Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT
August 22, 2025
Hofseth Biocare ASA: HBC’s ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago
July 16, 2025
Hofseth Biocare ASA: Annual General Meeting completed
May 23, 2025
Hofseth Biocare ASA: FIRST QUARTER 2025 FINANCIAL REPORT
May 16, 2025
Hofseth Biocare ASA: NESTLÉ GARDEN OF LIFE LAUNCHES HBC OMEGO® FULL SPECTRUM OMEGAS IN THE US
May 5, 2025
Hofseth Biocare ASA: SUCCESSFUL PLACEMENT OF NEW CHF-DENOMINATED UNSECURED BONDS
May 5, 2025
Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2025
May 2, 2025
Decks
- Investor Presentation (March 2024)
Investor deck · 23 slides · March 2024